The Hill is hosting its third annual live event focused on getting the most value from Medicare benefits in 2027. This year's program, produced in partnership with the Alliance on Aging Research, expands beyond prescription drug plans to address the most common questions beneficiaries face during open enrollment, which runs from Oct. 15 to Dec. 7.
Healthcare affordability remains a top financial worry for Americans, and for Medicare enrollees and their families, open enrollment is a critical window to review coverage before the 2027 plan year begins. New survey research reveals significant gaps in awareness of newer cost-saving benefits, and the impact of Medicare's drug price negotiation program on Part D access and out-of-pocket costs is mixed, according to experts.
The event will bring together policymakers, enrollment specialists, and patient advocates to discuss the future of Medicare benefits, the effects of drug price negotiations, and what beneficiaries should watch for in 2027. As 2027 enrollment brings higher costs and new drug deals, understanding these changes is essential for making informed choices.
Medicare has also added 15 Part B drugs to the third round of price negotiations, a move that could affect patient access. Additionally, the administration has taken steps to formalize negotiation policies that may discourage the development of biosimilars and alternative therapies with improved delivery methods. These policy shifts are part of a broader trend that CMS leaders warn could require enrollees to reassess their plans as drug prices shift.
For beneficiaries, the key takeaway is to not assume your current plan will still be the best fit. Premiums, formularies, and out-of-pocket costs can change annually, and new benefits may be available. The event aims to demystify the process, offering practical advice on comparing plans, understanding coverage changes, and maximizing benefits.
One of the most pressing issues is the lack of awareness about cost-saving programs. Many beneficiaries are eligible for extra help or subsidies but don't take advantage of them. The discussion will highlight these opportunities and how to access them.
Another focus will be on the long-term implications of drug price negotiations. While some patients have seen lower costs, others face limited access to certain medications. The event will explore the trade-offs and what patients can do if their medication is no longer covered.
The live stream is scheduled to begin at 2 p.m. EDT. Viewers can watch the full discussion above, and the conversation will be archived for later viewing. For those navigating the complexities of Medicare, this event offers a timely opportunity to get answers from experts and advocates.
